Access to vaccines index 2017

This report explores the landscape of vaccine industry activity in order to improve immunisation coverage. International agreements, including the Global Vaccine Action Plan and Sustainable Development Goals, set out clear targets to improve access to vaccines worldwide. Achieving these targets requires a coordinated framework of multiple stakeholders, including governments, multilateral organisations, purchasers, funders, vaccine developers and manufacturers.

The Index analyses eight key vaccine companies and uses 13 metrics to measure company performance relating to 69 vaccine-preventable diseases in 107 countries in three areas of behaviour: Research & Development; Pricing & Registration; and Manufacturing & Supply. The Index metrics reflect stakeholders’ views on how vaccine companies can contribute to global immunisation targets. 

The Index provides an initial baseline of company activity on access to vaccines. This information can be used to inform priorities and learn where new incentives or stronger mechanisms would spur companies towards greater engagement in access issues.  The document presents the following opportunities: 

• Continue to make strong investments in R&D;
• Expand processes to respond to vaccine shortages;
• Aim toward product attributes that meet needs of populations in scope;
• Continue to share expertise with local manufacturers;
• Put pricing strategies in place for new vaccines.